openPR Logo
Press release

Urolithiasis Management Devices Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

Urolithiasis Management Devices Market

Urolithiasis Management Devices Market

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Urolithiasis Management Devices Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.05 billion In 2028 At A CAGR Of 6.6% :

The urolithiasis management devices market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in healthcare expenditure and investments in urological care, the aging population leading to a higher incidence of urolithiasis, expansion of healthcare infrastructure in developing regions, regulatory approvals and guidelines promoting the safety and efficacy, and sedentary lifestyles

The urolithiasis management devices market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing awareness about minimally invasive procedures, growing incidence and recurrence of urolithiasis, continued advancements in endoscopic procedures, shift towards outpatient treatments due to cost-effectiveness and reduced hospital stays, and rising patient preference for non-invasive treatment options. Major trends in the forecast period include continued innovation in device technology, emphasis on patient comfort and safety, the integration of robotics and artificial intelligence (AI) in urolithiasis management devices, and advancements in molecular diagnostics and genetic profiling.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15691&type=smp

Urolithiasis Management Devices Market Major Segments
The urolithiasis management devices market covered in this report is segmented -

1) By Product Type: Lithotripters, Ureteroscopes
2) By Treatment Type: Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types
3) By End Users: Hospitals, Clinics, Ambulatory Surgical Centers

Key Driver - Surge In Military And Defense Spending Boosts Night Vision Devices Market Growth

The rising prevalence of kidney diseases is expected to propel the growth of the urolithiasis management devices market going forward. Kidney disease, also known as renal disease or nephropathy, refers to a condition in which the kidneys are damaged and their function is impaired. The factors driving the rising prevalence of kidney diseases include increased consumption of animal proteins, a lack of physical activity, and rising obesity rates. Urolithiasis management devices enable healthcare professionals to perform precise interventions, relieve obstruction, prevent complications, and improve patient outcomes in cases of urolithiasis-related kidney issues. For instance, in June 2023, according to Kidney Research UK, a UK-based charity organization, the incidence of acute kidney injury is expected to increase from an estimated 615,000 episodes in 2022 to 637,000 by 2033. Therefore, the rising prevalence of kidney diseases is driving the growth of the urolithiasis management devices market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15691&type=smp

Prominent Trend - Exciting Technology-Based Product Launches In The Urolithiasis Management Devices Market

Major companies operating in the urolithiasis management devices market are developing innovative, technology-based products, such as thulium fiber laser (TFL) technology-based laser machines, to gain a competitive edge in the market. Thulium Fiber Laser (TFL) technology represents an advanced laser system used in the management and treatment of urolithiasis, or urinary stones. For instance, in July 2023, Coloplast AS, a Denmark-based company engaged in urology-related medical devices and services, launched the Coloplast TFL Drive, the first laser product to grind kidney stones to dust. This innovative, all-in-one thulium fiber laser system is designed for lithotripsy, BPH (Benign prostatic hyperplasia) treatment, and precise soft tissue procedures. It delivers faster, safer treatments, offering surgical versatility and highly effective intra-operative performance using the latest Thulium Fiber Laser (TFL) technology.

Urolithiasis Management Devices Market Players
Major companies operating in the urolithiasis management devices market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, NOVAmedtek, Coloplast Group, Rocamed SAM, DirexGroup, Cook Medical Inc., Karl Storz SE & Co. KG, C. R. Bard Inc., MTS Medical LLC, Richard Wolf GmbH, Wellspect HealthCare, Dornier MedTech GmbH, EDAP TMS, EMS Electro Medical Systems SA, Shenzhen Huikang Medical Apparatus, Storz Medical AG, Allengers Medical Systems, JenaSurgical GmbH, ELMED Medical Systems, Allium Medical Solutions Ltd., Elmed Lithotripsy Systems Inc., Inceler Medikal Co. Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/urolithiasis-management-devices-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the urolithiasis management devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urolithiasis management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Urolithiasis Management Devices Market Report Structure
3. Urolithiasis Management Devices Market Trends And Strategies
4. Urolithiasis Management Devices Market - Macro Economic Scenario
5. Urolithiasis Management Devices Market Size And Growth
…..
27. Urolithiasis Management Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urolithiasis Management Devices Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033 here

News-ID: 3547240 • Views:

More Releases from The Business research company

Herpes Simplex Virus Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | GlaxoSmithKline plc, Carlsbad Technology Inc., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG, Apotex Inc., Mylan N.V., Teva Pharmaceuticals
Herpes Simplex Virus Treatment Global Market Report 2024 - Market Size, Trends, …
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10691&type=smp Surge In Sexually Transmitted Infections Propels Growth Of Herpes Simplex Virus Treatment Market The surge in the prevalence of sexually transmitted infections is expected to propel the growth of the herpes simplex virus treatment market going forward. Sexually transmitted diseases (STDs) or sexually transmitted infections (STIs) refer to an illness brought on by an infection with specific bacteria, viruses, or other microorganisms that can be spread
Herpangina Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Gilead Sciences Inc., Johnson and Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Vertex Pharmaceuticals Incorporated, Sanofi S.A, Nov
Herpangina Treatment Global Market Report 2024 - Market Size, Trends, And Global …
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10855&type=smp Growing Prevalence Of Herpangina Treatment Fuels The Growth Of The Herpangina Treatment Market The rise in prevalence of the herpangina is expected to propel the growth of the herpangina treatment market going forward. Herpangina is a viral illness that usually affects youngsters, creating painful sores or ulcers on the tonsils and back of the throat caused by coxsackievirus and enteroviruses. Herpangina therapy helps to reduce the
Hereditary Angioedema Therapeutics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Shire plc, Sanofi S.A., Pharming Healthcare Inc., Attune Pharmaceuticals Inc., Adverum Biotechnologies Inc., Arrowhead Pharmaceuticals Inc.
Hereditary Angioedema Therapeutics Global Market Report 2024 - Market Size, Tren …
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10810&type=smp Surging Prevalence Of Hereditary Angioedema Ignites Growth In The Market The rising prevalence of hereditary angioedema is expected to propel the growth of the hereditary angioedema market going forward. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling of the skin and mucous membranes. The swelling is caused by excess fluid build-up (EDEMA) and can occur anywhere in the body,
Herbicides Safener Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | BASF SE, Bayer AG, Syngenta AG, Adama Agricultural Solutions Ltd., Arysta LifeScience Corporation, Drexel Chemical Company, Winfield United LLC, Sipcam-Oxo
Herbicides Safener Global Market Report 2024 - Market Size, Trends, And Global F …
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10250&type=smp The Surge In Herbicide Utilization And The Herbicides Safener Market's Growth Trajectory The increasing use of herbicides is expected to propel the growth of the herbicides safener market going forward. Herbicide refers to a type of pesticide that is used to kill or control unwanted plants and weeds. The herbicides are mostly driven by herbicide-resistant weeds, demand for higher crop yields, and improper application of herbicides,

All 5 Releases


More Releases for Urolithiasis

Urolithiasis Management Devices Market Will Exhibit a Healthy 4.5% CAGR
Despite the presence of a large number of regional players, the global market for urolithiasis management devices is dominated by few large vendors having substantial budgets for research and development of new technologies and innovative products, observes TMR in a recent report. Companies such as Boston Scientific Corporation, C. R. Bard, Inc., and Cook Group command prominent positions in the global market owing to their strong geographic presence, excellent distribution
Urolithiasis Management Devices Market | Key Opportunities And Forecast 2024
Despite the presence of a large number of regional players, The Global Market For Urolithiasis Management Devices is dominated by few large vendors having substantial budgets for research and development of new technologies and innovative products, observes TMR in a recent report. Companies such as Boston Scientific Corporation, C. R. Bard, Inc., and Cook Group command prominent positions in the global market owing to their strong geographic presence, excellent distribution
Urolithiasis Management Devices Market | Key Trends and Opportunity Analysis 202 …
Despite the presence of a large number of regional players, The Global Market For Urolithiasis Management Devices is dominated by few large vendors having substantial budgets for research and development of new technologies and innovative products, observes TMR in a recent report. Companies such as Boston Scientific Corporation, C. R. Bard, Inc., and Cook Group command prominent positions in the global market owing to their strong geographic presence, excellent distribution
Urolithiasis Management Devices Market - Positive long-term growth outlook 2024
The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the
Urolithiasis Management Devices Market Research Report Forecast to 2024
Urolithiasis is development of kidney stones in the urinary system. It includes nephrolithiasis (development of kidney stones), ureterolithiasis (stone formation in ureters), and cystolithiasis (stone formation in the bladder). Urolithiasis is a common condition that affects at least 10% of the global population. Urinary stones are generally distinguished based on the location and chemical composition. Based on chemical composition, these are categorized into calcium, uric acid, and oxalate stones. Kidney stones
Global Urolithiasis Management Devices Market Trends & Industry Forecast by 2016 …
Urolithiasis is development of kidney stones in the urinary system. It includes nephrolithiasis (development of kidney stones), ureterolithiasis (stone formation in ureters), and cystolithiasis (stone formation in the bladder). Urolithiasis is a common condition that affects at least 10% of the global population. Urinary stones are generally distinguished based on the location and chemical composition. Based on chemical composition, these are categorized into calcium, uric acid, and oxalate stones. Kidney stones